CHAIR
:
SPEAKER
(S):
William Boni, Vice President, Investor Relations and Corporate Communications, ArQule, Inc.
Timothy Hunt, Vice President, Public Affairs, Biogen Idec, Inc
Lisa Adler, Vice President Corporate Communications, Millennium Pharmaceuticals, Inc
Description
As the biotechnology and biopharmaceutical industries evolve, the companies that fuel those industries are growing and changing. This session will examine how companies can reinvent themselves, suggest how companies can maintain their reputation while building a new identity and help companies determine how to communicate as a company changes.
Objectives:
Provide guidance to pharmaceutical and biotechnology companies on communication and messaging during pivotal times in companies' initial development, growth and restructuring.
Demonstrate how to build, protect and enhance corporate identity through a variety of internal communication strategies.
Illustrate how to best position and differentiate your company in the changing, competitive biotechnology and biopharmaceutical landscape.